ERC Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 8 (4) 265-286    DOI: 10.1677/erc.0.0080265
Copyright © 2001 by the Society for Endocrinology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singletary, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singletary, S.
Endocrine Related Cancer, Vol 8, Issue 4, 265-286
Copyright © 2001 by Society for Endocrinology


Articles

New approaches to surgery for breast cancer

SE Singletary


The surgical management of breast cancer is rapidly evolving towards less invasive procedures. Alternative biopsy techniques, including fine-needle aspiration and core needle biopsy, are replacing excisional biopsy as the treatment standard. Breast conservation therapy is now widely used in place of mastectomy, both for small tumors and for larger tumors that have been downstaged through induction chemotherapy. Less invasive procedures for axillary treatment such as lymphatic mapping and sentinel lymph-node biopsy are being explored in an effort to avoid the morbidity associated with axillary lymph-node dissection. For women who still prefer or need to receive a mastectomy, immediate breast reconstruction with autologous tissue provides an excellent cosmetic outcome that is oncologically sound. This is especially appealing to high-risk women who opt to have a prophylactic mastectomy. High-risk women are also being offered the option of receiving chemopreventive treatment that may reduce their lifetime risk of cancer by almost 50%. These new, less invasive approaches require the close cooperation of a team of physicians,including surgeons, pathologists, radiologists, and medical and radiation oncologists.


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
K.-D. Yu, G.-H. Di, J. Wu, J.-S. Lu, K.-W. Shen, Z.-Z. Shen, and Z.-M. Shao
Development and trends of surgical modalities for breast cancer in china: a review of 16-year data.
Ann. Surg. Oncol., September 1, 2007; 14(9): 2502 - 2509.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. M. Kuerer and L. A. Newman
Lymphatic Mapping and Sentinel Lymph Node Biopsy for Breast Cancer: Developments and Resolving Controversies
J. Clin. Oncol., March 10, 2005; 23(8): 1698 - 1705.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. El-Tamer, R. Saouaf, T. Wang, and R. Fawwaz
A New Agent, Blue and Radioactive, for Sentinel Node Detection
Ann. Surg. Oncol., April 1, 2003; 10(3): 323 - 329.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Endocrinology.